SAB BIOTHERAPEUTICS, INC. Shares Issued, Shares, Share-based Payment Arrangement, Forfeited
SAB BIOTHERAPEUTICS, INC. (SABS) reported Shares Issued, Shares, Share-based Payment Arrangement, Forfeited of 375.00 thousand shares for the 2-month period ending 2020-12-31, per its 10-K filed 2021-04-02.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited · last filed 2021-04-02
- 2020-12-31: Shares Issued, Shares, Share-based Payment Arrangement, Forfeited 2 month 375.00K shares.
| Period end | Shares Issued, Shares, Share-based Payment Arrangement, Forfeited 2 month |
|---|---|
| 2020-12-31 | 375.00K shares 10-K · filed 2021-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |